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Abstract
Albumen was removed from broiler eggs before the start of incubation to induce prenatal protein under-nutrition in chicken embryos.
With this method, the direct effect of protein deficiency was investigated, differing from mammalian models manipulating the maternal
diet where indirect, hormonal effects can interfere. Based on the estimated albumen/egg weight ratio, 10 % of albumen was removed
with an 18G needle, after making a hole at the sharp end of the egg with another 18G needle. Eggs were taped thereafter. The sham
group underwent the same procedure, except that no albumen was removed. Control eggs did not receive any treatment. The removal
of albumen decreased both embryonic and post-hatch body weight up to day 7 compared with the control group. On embryonic
day 18, embryos from the albumen-deprived group had higher plasma uric acid levels compared with the sham (P¼0·016) and control
(P¼0·009) groups. Moreover, a lower plasma amino acid concentration was observed at hatch compared with the sham (P¼0·038) and
control (P¼0·152) groups. These findings indicate an altered protein metabolism. At hatch, a higher mRNA expression of muscle ring
finger-1 (MuRF1), a gene related to proteolysis, was observed in albumen-deprived chicks compared with the control and sham chicks,
together with an up-regulated expression of atrogin-1 (another atrogene) at this time point in the male protein-deficient chicks. These
findings suggest that muscle proteolysis is transiently increased by the removal of albumen before the start of incubation. No evidence
was found for altered protein synthesis capacity and translational efficiency in albumen-deprived chicks.
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The two major components of an egg, i.e. albumen and yolk,
differ in biochemical composition and accomplish different
functions during embryonic and postnatal development(1).
The yolk is the main source of lipids, whereas the albumen is
a key source of water and proteins(2). Changes in relative yolk
and albumen ratio are considered to be an important mechan-
ism of maternal effects. Therefore, recent studies have been per-
formed on the removal of albumen from barn swallow eggs(3,4)
and yellow-legged gull eggs(5). In addition, the removal of albu-
men from an egg is useful as a model to study the direct effect of
nutrient deficiency during embryonic development(6) on the
growth and metabolism of the newborns. This model differs
from the model of protein under-nutrition during embryonic
development induced by manipulations of the maternal diet,
which can be considered as an indirect model where the
effect of maternal hormones can interfere. Rats and mice have
been used extensively to look for the effect of maternal diet
on the programming of the progeny. Recently, also in chickens,
the effect of a low-protein diet on the metabolic programming
of the progeny was investigated(7). Studying these two models
(direct and indirect effects of nutrient deficiency) can give us
a better understanding of the effect of restricting nutrients or
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both nutrients and maternal hormones. Interestingly, besides a
decreased embryo and chick weight at hatch(6,8,9) due to
albumen removal, Ruijtenbeek et al.(10) and Miller et al.(11)
also found disproportionate growth retardation. Moreover,
Muramatsu et al.(12) observed a reduced whole-body protein
synthesis by the removal of albumen from eggs before
incubation. However, further knowledge is lacking.
Amino acids are substrates for protein synthesis and are also
known to act as modulators of signal transduction pathways
that control metabolism. In particular, certain amino acids
affect the activity of several proteins involved in the control
of mRNA translation, such as 4E-binding protein (4E-BP1),
70 kDa S6 kinase (p70S6K, also called S6K1) and one of its
downstream targets, the ribosomal protein S6(13,14). Muscle
mass depends on the dynamic balance between the processes
of protein synthesis and degradation. In the last decade,
studies on gene expression profiling have highlighted genes
specifically induced during atrophy (atrophy-related genes,
also called atrogenes) and related to proteolysis, i.e. muscle
atrophy F box (MAFbx or atrogin-1) and muscle ring
finger-1 (MuRF1)(15,16). These genes encode muscle-specific
E3-ubiquitin ligases involved in the ubiquitination of proteins
targeted to the ubiquitin–proteasome-dependent proteolytic
system. It has been shown in the chicken that MuRF1 gene
expression was increased by fasting(17), and atrogin-1
gene expression was also increased by fasting(17,18), whereas
re-feeding or glycine supplementation suppressed it(18,19). In
addition, Tesseraud et al.(20) have shown that atrogin-1 and
MuRF1 were regulated in chickens transiently receiving
lower lysine intake in sequential feeding programmes.
The aim of the present study was to investigate the direct
effect of nutrient (protein) deficiency during chicken embryo-
nic development, by the removal of albumen from the egg
before incubation, on post-hatch performance, metabolism
and signalling. In the present study, we also focused on the
regulation of two important genes that control the polyubiqui-
tination and, thus, the degradation of proteins, by measuring
the expression of atrogin-1 and MuRF1 in breast muscle.
Materials and methods
Experimental design
A total of 1230 fertile Cobb eggs (Belgabroed) were numbered
and weighed. From thirty eggs, albumen weight and yolk
weight were determined. The ratio of albumen weight/egg
weight was used to estimate the albumen content in all
eggs. From 800 eggs (albumen-deprived group), based on
their initial egg weight and on the estimated albumen/egg
weight ratio, 10 % of albumen was removed at the sharp
end of the egg with a 18G needle and syringe after cleaning
the egg with 70 % ethanol. After albumen removal, eggs
were cleaned again with ethanol and taped. In 200 other
eggs, a hole was made at the sharp end of the egg with a
needle (18G), through the membranes, and taped thereafter
to give the sham group. The other 200 eggs served as a control
group. All eggs were set in one incubator (Pasreform) and
incubated under standard conditions (37·88C, 55 % relative
humidity, turning once an hour over 908) with the blunt end
upside. On embryonic day (ED) 18, all eggs were candled
and those with living embryos were transferred to hatching
baskets. At hatch, all chicks were weighed and numbered.
Hatchability was defined as hatched chicks £ 100/all set
eggs. The sex was determined by cloacal sexing (Hobo
Chick Sexing B.V.B.A.). All chicks received a leg number
and were housed for 1 week in a poultry house, with wood
shavings as litter. Chicks had ad libitum access to food and
water. The light schedule provided 23 h of light per d.
Chicks were weighed on days 3, 5 and 7.
Sampling
On ED18, ten embryos per treatment were poured out of the
egg and weighed after the yolk was removed. The breast
muscle was dissected and snap-frozen in liquid N2 before sto-
rage at 2808C. The water content of the remaining chick was
measured by drying the chick in an oven for 24 h at 1058C.
At hatch, before cloacal sexing, twelve chicks from each
treatment (albumen-deprived, control and sham) were killed
by decapitation and the blood was collected in heparinised
tubes. The yolk was weighed and proportional yolk weight
was defined as yolk weight £ 100/chick weight. The breast
muscle was dissected and snap-frozen in liquid N2 before sto-
rage at 2808C. The sex was determined after dissection. There
were eight, six and nine females for the albumen-deprived,
control and sham groups, respectively, and, hence, four, six
and three males for these groups, respectively. The water con-
tent of the remaining chicks was measured by drying the
chicks in an oven for 24 h at 1058C.
On days 3, 5 and 7, eight chicks of each sex per treatment
were killed by decapitation to collect the blood in heparinised
tubes and to dissect the breast muscle. The tissue was snap-
frozen in liquid N2 before storage at 2808C.
The experimental set-up was approved by the Ethical Com-
mission for Experimental Use of Animals of the KU Leuven.
Sexing chick embryos of embryonic day 18
A small piece of breast muscle tissue of embryos of ED18 was
used to determine the sex, as described by Clinton et al.(21). In
short, DNA was extracted and a PCR was performed using sex-
specific (Xhol, present on the W-chromosome of females) and
control (18S) primers.
Plasma analysis
Blood was centrifuged and the plasma was stored at2208C until
further analysis. The amino acid concentration in the plasma
was determined as described by Dupont et al.(17). Plasma glu-
cose (VetTest 9820369), uric acid (VetTest 9820378) and TAG
(VetTest 9820377) concentrations were measured using a
Vet Test 8008 analyser (Idexx laboratories, Inc.). The apparatus
is based on dry chemical technology and colorimetric reaction.
Sample analysis is carried out on selective testing discs (Idexx
Laboratories, Inc.) by means of a laser reading the bar codes.

















Ribosomal capacity assessed in breast muscle tissue
The ribosomal capacity, i.e. the capacity for protein synthesis,
was calculated as the ratio of RNA to protein(22), according to
Schmidt-Thannhauser, as modified by Munro & Fleck(23). It is
an index related to the number of ribosomes and, thus, protein
synthesis machinery(24). In short, protein content was measured
by colorimetric reaction with bicinchoninic acid (Interchim).
Total RNA was measured on the basis of UV absorbance at
260 nm, with a correction for peptide material based on the
UV absorbance at 232 nm.
Atrogin-1 and muscle ring finger-1 expression
in the breast muscle
Total RNA was extracted from the breast muscle samples at
ED18, hatch, day 3 and day 7 using RNA Now (Biogentec),
according to the manufacturer’s recommendations. Concen-
trations of RNA were measured by spectrophotometry (optical
density 260 nm), and RNA integrity was electrophoretically ver-
ified using ethidium bromide. After DNAse treatment (Ambion,
Clinisciences), RNAwas reverse-transcribedusing Super Script II
RNase H Reverse Transcriptase (Invitrogen) in the presence of
Random Primers (Promega). Real-time PCR was performed
using an ABI Prism 7000 apparatus (Applied Biosystems) with
primers, as described in Table 1. mRNA levels were estimated
on the basis of PCR efficiency and threshold cycle (Ct) deviation
of an unknown sample v. a reference sample. Runs were per-
formed in duplicate. 18S mRNA was chosen as the reference
gene to standardise the mRNA expression of each gene.
Preparation of breast muscle lysates and Western blotting
Breast muscle lysates from hatch and day 7 were prepared, as
described previously(25). Tissue lysates (40mg protein) were
subjected to SDS-PAGE gel electrophoresis and Western blotting
using the appropriate antibody: anti-phospho-Thr389 S6K1,
anti-phospho-Ser235/236 S6, anti-phospho-(Thr34/46) 4E-BP1
or anti-S6 (Cell Signaling Technology); anti-S6K1 (Santa Cruz
Biotechnology); or anti-vinculin (Sigma Chemical Company).
These commercial antibodies directed against mammalian
proteins have been previously shown to cross-react with
chicken homologue protein to a good extent(25,26). After wash-
ing, membranes were incubated with an Alexa Fluor secondary
antibody (Molecular Probes, Interchim). Bands were visualised
by IR fluorescence using the Odysseyw Imaging System
(LI-COR, Inc. Biotechnology) and quantified by Odyssey infra-
red imaging system software (application software, version 1.2).
Statistical analysis
All data were processed using the statistical software package
SAS version 9.2 (SAS Institute Inc.). Linear models were
applied to analyse the effect of treatment (albumen-deprived,
control and sham), sex (female or male) and age (ED18, hatch,
day 3, day 5 and day 7) on the measured parameters using
general linear models in SAS. Post hoc tests are only applied
for pertinent significant effects in the models.
Due to an age and sex effect and age, sex and treatment
interaction on 18S, results of the target gene expression
were analysed and presented with and without normalisation
with 18S. In addition, due to these effects on 18S, the mRNA
levels of the genes/18S were analysed per sex and per time
point. A log transformation was used to obtain homogeneity
of variances for all data on gene expression.
A logistic regression model was developed to analyse the
hatchability. The treatment served as a categorical explanatory
variable in the model.
Body weight was analysed by the use of repeated measure-
ments in a linear mixed model after a log transformation, con-
taining age, treatment and sex and their interactions as factors.
Data used for chick weight were only those from chicks that
remained in the experiment until day 7. Differences between
treatments were analysed by the specification of contrasts
based on the significant model.
For all parameters, significance was set at a 5 % level. All
values are expressed as means, with their standard errors.
When no sex effect was observed, no distinction between
sexes is shown in the tables or figures.
Results
Zootechnical results
The albumen weight was 55·5 (SEM 0·4) % of the egg weight,
as an average of the thirty eggs was used to determine the
albumen/egg weight ratio. About 4 g of albumen was removed
from the experimental group (Table 2). The removal of albu-
men increased embryonic death (treatment P,0·001), result-
ing in a very low hatchability compared with the sham and
control groups (both P,0·001). Moreover, the sham group
exhibited a significantly lower hatchability compared with
the control group (P,0·001). No difference in the number
of hatched females or males was observed between treatments
(no sex effect or sex £ treatment interaction). On ED18, there
was a significant treatment effect (P,0·001) on embryo
weight, but no sex effect or sex £ treatment interaction.
Embryos from the albumen-deprived group were lighter
than those of the control group (P,0·001), while the sham
group had intermediate values (Table 2). There was no differ-
ence in water content of the embryos on ED18 between treat-
ment or sex, nor was there any interaction. There was no sex
effect on embryo weight and water content of the embryo/
chick on ED18 or at hatch. At hatch, chick weight and the
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water content of the chicks used for sampling differed signifi-
cantly between treatments (treatment P,0·001 for both par-
ameters). The chick weight at hatch was lower in the
albumen-deprived group compared with both the sham and
the control groups (albumen-deprived v. control and sham
both P,0·001) (Table 2). The remaining yolk weight and the
proportional yolk weight at hatch did not differ between treat-
ment or sex, nor was there any interaction (Table 2).
The body weight from hatch until day 7 is shown in Fig. 1.
A log transformation was performed on the raw data to obtain
homogeneity of variances. There was a general treatment and
age effect (both P,0·001). There was an interaction between
sex and treatment (P¼0·008) on body weight from hatch until
day 7. Female chicks from the albumen-deprived group had a
lower body weight compared with control (P,0·001) and
sham (P,0·001) female chicks on all measured time points.
Female sham chicks did not differ from female control chicks.
Male albumen-deprived and sham chicks had a lower body
weight compared with control male chicks on all measured
time points (both P,0·001).
Plasma analysis
There was a significant effect of age (P¼0·025), treatment
(P¼0·013) and sex x age interaction (P¼0·001) on plasma
amino acid concentration. In general, the albumen-deprived
group had significantly lower amino acid levels than the sham
group (P¼0·015) and was marginally significantly different
from the control group (P¼0·058), while the sham and the con-
trol groups did not differ from each other (Fig. 2). Females had
a higher amino acid concentration compared with males on
day 7 (P¼0·021). Plasma uric acid concentration increased with
age (P,0·001) and did not differ between sexes (Fig. 3). There
was a significant interaction between treatment and age
(treatment £ age P¼0·001). On ED18, the albumen-deprived
group had higher levels than the control (P¼0·009) and sham
groups (P¼0·016). At hatch, the albumen-deprived group
had lower levels than the sham group (P¼0·031) and the levels
of the control group were intermediate. Plasma glucose
concentration increased with age until day 5 and decreased on
day 7 (age P,0·001), without differences among sex, treatment
Table 2. Egg weight before and after removal of albumen (g), hatchability, yolk-free embryo weight on embryonic day (ED) 18 (n 10)
and water content of the yolk-free embryo (%), chick weight at hatch (g), water content of the yolk-free chicks (%) (n 12), yolk weight (g)
and proportional yolk weight at hatch (%)
(Mean values with their standard errors)
Albumen-deprived Control Sham
Mean SEM Mean SEM Mean SEM
Egg weight before removal (g) 63·7 0·1 64·1 0·3 63·8 0·3
Egg weight after removal (g) 59·6b 0·1 64·1a 0·3 63·8a 0·3
Hatchability* (%) 10c 82b 34a
Embryo weight on ED18 (g) 25·8b 0·7 29·7a 0·4 27·7a,b 0·4
Water content of embryo on ED18 (%) 82·7 0·6 81·7 0·4 82·2 0·4
Chick weight at hatch (g) 43·8b 0·3 48·5a 0·2 48·8a 0·4
Water content of yolk-free chick at hatch (%) 79·8b 0·3 81·0a 0·4 81·5a 0·4
Yolk weight at hatch (g) 7·8 0·3 8·9 0·5 8·6 0·4
Proportional yolk weight at hatch† (%) 18·3 0·7 17·9 1·1 18·1 1·0
a,b,c Values within a row with unlike superscript letters were significantly different (P,0·05).
* Hatchability ¼ number of chicks/number of set eggs £ 100.
† Proportional yolk weight at hatch ¼ yolk weight/chick weight £ 100.
(A) (B)
Age












































Hatch Day 3 Day 5 Day 7
Fig. 1. Chick weight (g) by sex from hatch until day 7 post-hatch for the albumen-deprived (Al, ), control (C, ) and sham (S, ) groups. Values are means,
with standard errors represented by vertical bars. (A) For the females, n 15, 26 and 11 for the Al, C and S groups, respectively (Al v. C, P,0·001; Al v. S,
P,0·001; C v. S, P.0·05). (B) For the males, n 17, 26 and 10 for the Al, C and S groups, respectively (Al v. C, P,0·001; Al v. S, P.0·05; C v. S, P,0·001).
Only chicks remaining in the experiment until day 7 were used in the model (age P,0·001; treatment P,0·001; sex P.0·05 and sex £ treatment P¼0·008). The
specification of contrasts was used to analyse differences between treatments.

















or interaction (data not shown). Plasma TAG concentration
decreased with age (P,0·001), without an effect on sex, treat-
ment or interaction (data not shown).
Ribosomal capacity assessed in the breast muscle tissue
Only an age effect (P,0·001) was observed for the ribosomal
capacity of the breast muscle tissue. Levels decreased from
ED18 until hatch (Fig. 4). On day 3, the highest levels were
measured, which decreased again on day 7. The ribosomal
capacity did not differ between treatments or sex, nor was
there any interaction.
Signalling pathways related to mRNA translation
Fig. 5 shows the ratio of the phosphorylated to the total
protein for S6 and S6K1 and the ratio of phosphorylated
(p)-4E-BP1 to vinculin at hatch and on day 7. There was, at
both ages, no effect of sex, treatment or interaction on
p-S6(S235–236)/S6 and p-S6K1(T389)/S6K1. In addition,
Western blot analysis revealed no differences among treat-
ments, sex and interaction for p-S6(S235–236)/vinculin,
S6/vinculin, S6K1/vinculin at hatch and on day 7 (data not
shown). At hatch, there was no treatment, sex or interaction
effect on p-S6K1(T389)/vinculin (data not shown) and p-4E-BP1/
vinculin. On day 7, p-S6K1(T389)/vinculin (data not shown) and
p-4E-BP1/vinculin levels were higher in females than in males
(P¼0·003) (Fig. 5).
Atrogin-1 and muscle ring finger-1 mRNA expression
in breast muscle
There was a significant effect of age (P,0·001) and sex
(P¼0·014) and interaction among sex, treatment and age
(sex £ treatment £ age P¼0·049) on the gene expression of
18S (Fig. 6).
The mRNA expression of atrogin-1 and atrogin-1/18S in the
breast muscle is shown in Fig. 7. There was a significant effect
of treatment (P¼0·007), age (P,0·001) and sex (P¼0·001) on
atrogin-1 expression. Levels were low on ED18 and increased
at hatch to decrease again on day 3 and day 7. In general, the
albumen-deprived group differed significantly from the
sham group (P¼0·011), but not from the control group.
When atrogin-1/18S expression was analysed per day and
sex, no differences were observed between the treatments.
The expression of MuRF1 revealed a significant effect of age
(P,0·001), sex (P¼0·041), treatment (P¼0·014), interaction
between age and treatment (age £ treatment P¼0·001) and
interaction among age, sex and treatment (age £ sex £
treatment P¼0·002). On ED18, levels were lower compared
with other sampling days (Fig. 8). At hatch, for the females,
higher MuRF1 levels were observed in the albumen-deprived
group compared with the control group (P¼0·002), while the
sham group was intermediate. For the males at hatch, higher
MuRF1 levels were observed in the albumen-deprived group
compared with the sham group (P¼0·043), with intermediate



































































Hatch Day 3 Day 7
Age
Hatch Day 3 Day 7
Fig. 2. Plasma amino acid concentration (mg L-serine equivalents/ml) in chicks from the albumen-deprived ( ), control ( ) and sham ( ) groups at hatch, and on
days 3 and 7 post-hatch (n 8 per treatment and per sex, except at hatch, where (A) n 8, 6 and 9 for the females of the albumen-deprived, control and sham
groups, respectively and (B) n 4, 6 and 3 for the males of the albumen-deprived, control and sham groups, respectively). Values are means, with standard errors
represented by vertical bars. a,b Means values with unlike letters were significantly different for each time point (P,0·05).
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Fig. 3. Plasma uric acid concentration (mmol/l) in chicks from the albumen-
deprived ( ), control ( ) and sham ( ) groups at embryonic day (ED) 18,
hatch and on days 3 and 7 post-hatch (n 10 per treatment on ED18; n 12 per
treatment at hatch; and n 16 at days 3 and 7). Values are means, with stan-
dard errors represented by vertical bars. a,b Means values with unlike letters
were significantly different for each time point (P,0·05).

















per sex, per day. At hatch, the female albumen-deprived chicks
had higher MuRF1/18S mRNA levels compared with the control
group (P¼0·010) and the sham group (P¼0·051), the latter only
numerically differing from the albumen-deprived females.
No difference was found in the males between the albumen-
deprived and sham groups.
Discussion
As proposed by Hill(6), the approach of removal of albumen
before incubation can offer a unique avian model that enables
the direct assessment of the independent influence of protein
on growth and metabolism. In contrast, most animal models
use mammals in which one can only examine the influence
of nutrition on fetal development indirectly, typically by manip-
ulating the mother’s nourishment. In the present model, the
removal of protein by the removal of albumen clearly
decreased both embryonic and post-hatch growth. The
reduced embryo weight is in agreement with Deeming(8),
who compared albumen-deficient embryos (by the removal
of 5 ml on day 3 of incubation) with untreated control embryos
and found a decreased wet and dry embryo weight from
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Fig. 4. Ribosomal capacity (mg RNA/g protein) in breast muscle of chicks
from the albumen-deprived ( ), control ( ) and sham ( ) groups on
embryonic day (ED) 18, at hatch and on days 3 and 7 (n 10 per treatment on
ED18 and n 12 per treatment on the other sampling time periods). Values

























































































































Fig. 5. Phosphorylation levels presented as ratios of phosphorylated (p)-S6K1(T389):S6K1, p-S6(S235–236):S6 and p-4E-BP1(T34/46):vinculin at (A) hatch and
(B) on day 7 in the breast muscle of the albumen-deprived (Al, ), control (C, ) and sham (S, ) groups (n 12 per treatment at hatch and n 16 per treatment on
day 7). Representative Western blots performed using antibodies raised against p-S6K1(T389), S6K1, p-S6(S235–236), S6, p-4E-BP1(T34/46) and vinculin as a
protein-loading control. F, female; M, male; S6K1, 70 kDa S6 kinase; 4E-BP1, 4E-binding protein; au, arbitrary units. Values are means, with standard errors
represented by vertical bars.

















ED14 onwards. As albumen consists of 88·5 % water and 10·5 %
protein(27), it is important to take the water content of the
embryos/chicks into account. While the water content
of the embryos was not affected by albumen removal on
ED18, the water content of the yolk-free chicks was signifi-
cantly reduced in the albumen-deprived group. However, the
decreased water content in the albumen-deprived group
cannot completely explain the 10 % decrease in body weight
at hatch. Interestingly, Miller et al.(11) also noted a decreased
body weight at hatch of chicks exposed to protein malnutrition,
without changes in chick length and together with a relative
sparing of some organs such as brain and heart. Yolk consump-
tion was not affected by albumen deprivation, measured by the
residual yolk weight, which is in agreement with the results of
Deeming(8). The removal of albumen had a persistent effect
on post-hatch body weight up to day 7, compared with the
control chicks. When compared with the sham group, albumen
removal had long-term effects on the growth rate of females,
with smaller differences for males, which is in agreement with
the study of Hill(6), who only compared albumen-deficient
chicks with a sham group. The low hatchability of the
albumen-deprived group is in agreement with Hill(6), who
had a hatchability of 15 % when removing 8 % of albumen,
and Finkler et al.(9). In contrast, Miller et al.(11) had a hatchability
of 45 %, with 10 % albumen removal, and ascribed the better
result to the careful use of sterile techniques. During the present
experiment, we did not work in a sterile environment, which
might have had a detrimental effect on the embryonic survival
of both the sham and the albumen-deprived eggs. However,
Finkler et al.(9) also worked under sterile conditions, but
obtained a low hatchability in the albumen-deprived group,
but not in the sham group. In addition, they observed an altered
metabolic rate, embryo dry and wet weight and organ weights
on ED20 of the sham group compared with the untreated con-
trol group(9). In the present study, the sham group also had a
retarded growth, which was more pronounced for the males
than for the females. By perforating the shell membranes in
both the sham and the albumen-deprived group, it could be
that the chalazae – a ropy structure of spirals from the yolk
into the albumen at either end of the egg(28) – were damaged.
Age
















Fig. 6. mRNA levels of 18S from embryonic day (ED) 18 until day 7 in
females ( ) and males ( ). Values are means, with their standard errors
represented by vertical bars (on ED18, n 12–13 per sex; at hatch, n 23 for
the females and n 13 for the males; and on days 3 and 7, n 24 per sex).
a,b Mean values with unlike letters were significantly different (P,0·05). Age
(P,0·001) and sex (P¼0·014). au, Arbitrary units.
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Fig. 7. Expression of atrogin-1 from embryonic day (ED) 18 until day 7 in (A) females and (B) males of the albumen-deprived ( ), control ( ) and sham ( )
groups. Relative expression of atrogin-1:18S from ED 18 until day 7 in (C) females and (D) males of the albumen-deprived, control and sham groups. Values are
means, with their standard errors represented by vertical bars (on ED18, n 4–5 per treatment and per sex. At hatch, n 8, 6 and 9 for the females of the albumen-
deprived, control and sham groups, respectively; and n 4, 6 and 3 for the males of the albumen-deprived, control and sham groups, respectively. On days 3 and
7, n 8 per treatment and per sex). au, Arbitrary units.

















As the chalazae serve to stabilise the position of the yolk, keep-
ing it at the geometric centre of the egg, it could be that during
turning, yolk–ovum security was affected. As the position of the
yolk was disturbed by the damaged chalazae, the formation of
other compartments, such as the albumen sac, might be dis-
turbed, preventing movement of proteins from the albumen
into the amnion through the sero-amniotic connection. There-
fore, not only albumen removal, but also making a hole at the
sharp end of the egg, might have affected the embryonic
development.
As no differences were found in plasma glucose and TAG
concentrations, no further analysis on carbohydrate or lipid
metabolism was performed. Plasma uric acid concentration
was remarkably high in the albumen-deprived group com-
pared with the other groups on ED18, indicating a higher cat-
abolism of amino acids in the liver, used for gluconeogenesis.
These amino acids are derived from protein coming either
from consumed amniotic fluid or from tissue protein
reserves(29,30). The latter origin is more probable under these
experimental conditions, as one would expect less amniotic
fluid in albumen-deprived embryos, as albumen proteins are
transferred to the amniotic fluid via the sero-amniotic connec-
tion(27). At hatch, the plasma uric acid concentration was the
lowest in the albumen-deprived group, which is also observed
in chickens on a low-protein pre-starter diet(31), a diet pro-
vided from day 7(32,33) or day 14 onwards(34,35). This low
plasma uric acid concentration, together with a lower amino
acid concentration at hatch in the albumen-deficient chicks,
suggests an altered protein metabolism. In particular, the
lower amino acid concentration might indicate that fewer
building blocks are available for protein synthesis and
chick growth. These findings corroborate with the study of
Muramatsu et al.(12) in which it was shown that the removal
of albumen before incubation reduced whole-body protein
synthesis in the embryo on the 12th day of incubation. Such
a reduction in protein synthesis induced by albumen removal
may not be related to a lower capacity for protein synthesis,
which was not altered in the whole body(12), as in the breast
muscle (present study), as no difference in ribosomal capacity
in breast muscle tissue was observed. In the present experimen-
tal conditions, it can also be assumed that translation initiation
was not altered by the removal of albumen before incubation.
The amino acid-sensitive mammalian target of rapamycin sig-
nalling pathway controls mRNA translation into proteins by
phosphorylation of S6K1, S6 and 4E-BP1. Here, the protein con-
tent and the level of phosphorylation of these proteins that play
a critical role in protein translation (i.e. S6K1, S6 and 4E-BP1)
were unaffected in the breast muscle. This corresponds with
a rat study, where mothers were food restricted and the pro-
geny had unaltered S6K1 and p-S6K1 in muscle(36). Postnatally,
however, it was shown that the protein content in a diet given to
broilers during the first 5 d after hatch affected S6K1 and S6
activation in the breast muscle of 3-d-old chicks(37).
In the present study, a potential regulation of the two atro-
phy-related genes atrogin-1 and MuRF1 was explored. So far,
little is known on their regulation during the perinatal period.
Interestingly, at hatch, an over-expression of these atrophy-
related genes was observed with respect to ED18. This
appears consistent with the decrease in relative breast devel-
opment during the late embryonic period(38). From hatch

















































































ED18 Hatch Day 3 Day 7
Fig. 8. Expression of muscle ring finger-1 (MuRF1) from embryonic day (ED) 18 until day 7 in (A) females and (B) males of the albumen-deprived ( ), control ( )
and sham ( ) groups. Relative expression of MuRF1:18S from ED 18 until day 7 in (C) females and (D) males of the albumen-deprived, control and sham groups.
Values are means, with their standard errors represented by vertical bars (on ED18, n 4–5 per treatment and per sex. At hatch, n 8, 6 and 9 for the females of
the albumen-deprived, control and sham groups, respectively, and n 4, 6 and 3 for the males of the albumen-deprived, control and sham groups, respectively. On
days 3 and 7, n 8 per treatment and per sex). a,b Mean values with unlike letters were significantly different (P,0·05). au, Arbitrary units.

















onwards, MuRF1 levels did not change with age, while the
expression of atrogin-1 decreased with age until day 7.
From days 7 to 14, a decrease in the expression of atrogin-1
in skeletal muscle of broiler chicks has also been reported(39).
The level of expression of the two atrogenes was not
drastically increased by the removal of albumen in the
majority of cases. On ED18, no treatment-related differences
were observed, while at that time point, largely higher plasma
uric acid concentrations in the albumen-deprived group
could mean altered protein metabolism. The notable exception
was the higher expression of MuRF1 in albumen-deprived
chicks at hatch, when chicks did not have access to food yet
and plasma amino acid concentrations were lower compared
with the control and the sham groups. It should also be noted
that an up-regulated expression of atrogin-1 was seen at this
time point in the male protein-deprived chicks (by five
times), whereas the effect of treatment was not observed in
the females. There is evidence that MuRF1 and atrogin-1 do
not respond necessarily similarly on a certain treatment(40–44).
In the same way, the present study shows that the response
to treatment might also be sex specific, as atrogin-1 was
increased in males but not in females due to albumen depri-
vation. However, maybe on the basis that atrogin-1 seems to
represent as a relatively poor index of muscle proteolysis, con-
versely to MuRF1, which is clearly involved in the degradation
of myofibrillar proteins(45), the present findings suggest that
muscle proteolysis is transiently increased by the removal of
albumen before the start of embryonic development.
In conclusion, the present study shows that the removal of
albumen from eggs can offer an interesting model to study the
direct effect of protein availability during embryonic develop-
ment on postnatal growth and metabolism. The removal of
albumen before the start of incubation clearly affected postnatal
growth until day 7. Changes in plasma uric acid and amino acid
levels on ED18 and at hatch in the albumen-deprived group
indicate an altered protein metabolism. The present results
demonstrate that the expression of genes related to protein
degradation (atrogin-1 and, especially, MuRF1) was stimulated
by protein malnutrition at hatch, while no evidence was found
for altered protein synthesis capacity and translational
efficiency.
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